Boston Scientific achieves PMDA approval for its FARAPULSE PFA System in Japan. The company expects to launch the system in the country in the upcoming weeks.
Boston Scientific (BSX) closed at $83.08 in the latest trading session, marking a -0.5% move from the prior day.
Boston Scientific (BSX) closed at $84 in the latest trading session, marking a +0.1% move from the prior day.
Boston Scientific (BSX) possesses solid growth attributes, which could help it handily outperform the market.
Does Boston Scientific (BSX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Boston Scientific received FDA approval on the expanded indication for INGEVITY+ Pacing Leads. Data demonstrated this lead to be safe and effective for LBBA pacing.
Boston Scientific (BSX) closed the most recent trading day at $82.52, moving -1.19% from the previous trading session.
Boston Scientific Co NYSE: BSX is a global medical device manufacturer that's seeing a strong influx of investors as shares grind to new all-time highs. The company has a vast portfolio of devices to diagnose and treat medical conditions.
In the closing of the recent trading day, Boston Scientific (BSX) stood at $82.94, denoting a -0.14% change from the preceding trading day.